• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Dolutegravir-[d6]

General Information
Catalog: BLP-005216
CAS: 1407167-38-7
Molecular Formula: C20H13D6F2N3O5
Molecular Weight: 425.41
Chemical Structure
Dolutegravir-[d6]
Description Dolutegravir-[d6] is a deuterium labelled form of Dolutegravir. Dolutegravir is an antiretroviral medication used to treat HIV/AIDS.
Synonyms Dolutegravir D6
IUPAC Name (3S,7R)-2,2,7-trideuterio-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-9,12-dioxo-7-(trideuteriomethyl)-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide
Related CAS 1051375-16-6 (unlabelled)
Canonical SMILES CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O
InChI InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1/i1D3,9D2,10D
InChI Key RHWKPHLQXYSBKR-PXHBCRPZSA-N
Purity 95% by CP; 98% atom D
Solubility Soluble in DMSO, Methanol
Appearance Off-white to Pale Beige Solid
Storage Store at -20°C

Interested in our Service & Products?
Need detailed information?

USA
  • International: 1-631-504-6093
  • US & Canada (Toll free): 1-844-BOC(262)-0123
  • 45-16 Ramsey Road, Shirley, NY 11967, USA
  • Email: info@bocsci.com
  • Fax: 1-631-614-7828
UK
  • 44-20-3286-1088
  • 85 Great Portland Street, London, W1W 7LT
  • Email: info@bocsci.com
Copyright © 2025 BOC Sciences. All Rights Reserved.
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x